Charles River Labs Intl Stock
Charles River Labs Intl Stock
The price for the Charles River Labs Intl stock decreased slightly today. Compared to yesterday there is a change of -€0.550 (-0.370%).
With 23 Buy predictions and not a single Sell prediction Charles River Labs Intl is an absolute favorite of our community.
As a result the target price of 165 € shows a slightly positive potential of 10.15% compared to the current price of 149.8 € for Charles River Labs Intl.
Pros and Cons of Charles River Labs Intl in the next few years
Pros
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
B****
Cons
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Charles River Labs Intl vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Charles River Labs Intl | -0.370% | -0.597% | -1.803% | 70.421% | -13.235% | -16.778% | -41.938% |
| Ligand Pharmaceuticals | -0.570% | -2.235% | -2.778% | 92.308% | 5.422% | 161.194% | 34.564% |
| United Therapeutics | -1.530% | -0.429% | 5.568% | 95.860% | 14.042% | 128.137% | 184.971% |
| Ionis Pharmaceuticals Inc. | -1.960% | -1.110% | -1.566% | 169.073% | -5.650% | 98.698% | 80.264% |
Comments
Charles River Laboratories International (CRL) had its "outperform" rating reaffirmed by Evercore Inc.
Show more
Ratings data for CRL provided by MarketBeat
Charles River Laboratories International (NYSE:CRL) had its "buy" rating reaffirmed by analysts at TD Cowen.
Show more
Ratings data for CRL provided by MarketBeat
Charles River Laboratories International (NYSE:CRL) had its "buy" rating reaffirmed by analysts at TD Cowen.
Show more
Ratings data for CRL provided by MarketBeat